Ad
related to: bristol-myers squibb
Search results
Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline
Zacks via Yahoo Finance· 15 hours agoBristol Myers (BMY) doesn't possess the right combination of the two key ingredients for a likely...
FY2024 EPS Estimates for Bristol-Myers Squibb (NYSE:BMY) Reduced by William Blair
ETF DAILY NEWS· 23 hours agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Stock analysts at William Blair lowered their FY2024 earnings per share (EPS) estimates for Bristol-Myers Squibb in a research note issued to ...
Bristol-Myers Squibb (NYSE:BMY) Short Interest Down 5.7% in March
ETF DAILY NEWS· 22 hours agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) saw a significant decline in short interest in March. As of March 31st, there was short interest totalling 35,120,000 shares, a decline of 5.7% ...
Sumitomo Mitsui Trust Holdings Inc. Buys 172,769 Shares of Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 4 days agoSumitomo Mitsui Trust Holdings Inc. raised its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.2% during the fourth quarter, according to its most recent filing with the Securities ...
In the wake of Bristol-Myers Squibb Company's (NYSE:BMY) latest US$5.7b market cap drop,...
Simply Wall St. via Yahoo Finance· 4 days agoKey Insights Institutions' substantial holdings in Bristol-Myers Squibb implies that they have...
Bristol-Myers Squibb: Market Pessimism Won't Last Forever (NYSE:BMY)
Seeking Alpha· 2 days agoAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the...
Bristol-Myers Squibb (NYSE:BMY) Forecasted to Earn Q3 2024 Earnings of $1.70 Per Share
ETF DAILY NEWS· 7 days agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Equities researchers at Leerink Partnrs issued their Q3 2024 earnings per share (EPS) estimates for Bristol-Myers Squibb in a report issued on ...
Building a Better Future: Bristol Myers Squibb 2023 ESG Rep
3BL CSRwire· 6 days agoAs we navigate an increasingly complex global landscape, our cohesive strategy, inclusive of our ESG...
Bristol Myers Squibb (BMY) Advances While Market Declines: Some Information for Investors
Zacks via Yahoo Finance· 3 days agoBristol Myers Squibb (BMY) ended the recent trading session at $48.51, demonstrating a +0.48% swing...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers...
Morningstar· 6 days agoNEW YORK, April 12, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bristol-Myers Squibb Company ("Bristol Myers" or the "Company") (NYSE: BMY). Such investors are advised to contact Danielle Peyton at newaction@
